Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers.
LINGO-1, A TRANSMEMBRANE SIGNALING PROTEIN, INHIBITS OLIGODENDROCYTE DIFFERENTIATION AND MYELINATION THROUGH INTERCELLULAR SELF-INTERACTIONS.
[Neurophysiology in Guillain-Barré syndrome].
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Antagonism of histamine H4 receptor exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
Trimesta (Oral Estriol)
New Data Show Strong, Sustained Effects of TECFIDERA® (Dimethyl Fumarate) in Newly-Diagnosed and Early Disease Course Multiple Sclerosis Patients
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Onset of psoriasis upon interferon beta treatment in a multiple sclerosis patient.
Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis.
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE))
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Interferon-ß-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.
Preclinical studies of sex differences: a clinical perspective.
Burden of neurological conditions in Canada.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.

Pages